Product
Invest
Services
Jobs News Pricing
Search Startup, Person, Job, Ecosystem
Search
EN Arrow Down
PROTe-IN Logo

PROTe-IN

Italy

Employee Count 4-10
Is Incorporated? No
Foundation Date December 1, 2020

Description

https://www.prote-in.it/

Investments

Competitive Advantage

Our Business Model is an IP model that foresees licensing revenue streams of software, machinery and applications to Food manufacturers and ingredients players as you read in the slide you mention, in a traditional B2B setup, therefore including engineering blueprint fees and regional/recipes exclusivity deals. As you will appreciate better during our future sessions, our Business Plan assumes POC/R&D projects with said manufacturers to be sold (like Agthia, Kerry and IFF that are in discussion as we speak) and is projecting a conversion rate of the same project as per 33% into production roll-out deals, or licencing contracts if you will. In parallel, we aim also to start in Dubai’s Food Tech Valley our very own production line of collagen (15/20 USD/kg specialities with high marginality) utilising 12 bioreactors and selling the outcome at market price to B2B players, directly as PROTe-IN.

Detailed Info

Revenue Model Description

We are a Microbial Fermentation foodtech company that is delivering alternative protein, collagen and organic material to the B2B market. We will focus during the first few years merely on the Food applications, that will grant us the fastest traction. Our Business Model is an IP model that foresees licensing revenue streams of software, machinery and applications to Food manufacturers and ingredients players as you read in the slide you mention, in a traditional B2B setup, therefore including engineering blueprint fees and regional/recipes exclusivity deals. As you will appreciate better during our future sessions, our Business Plan assumes POC/R&D projects with said manufacturers to be sold (few under current examination) and is projecting a conversion rate of the same project as per 33% into production roll-out deals, or licencing contracts if you will. In parallel, we aim also to start in Dubai’s Food Tech Valley our very own production line of collagen (15/20 USD/kg specialities with high marginality) utilising 12 bioreactors and selling the outcome at market price to B2B players, directly as PROTe-IN.